Category Archives: News

The World’s Fastest Computer to Join Fight Against COVID-19

In our previous blog posts we have highlighted in the work of the Argonne National Laboratory (ANL) and Barcelona Supercomputing Center (BSC) that High Performance Computing (HPC) resources are an invaluable research tool. Much like their counterparts and colleagues around the world, Japan’s top scientists are now refocusing and accelerating their research efforts towards addressing…

AI-driven integrative biology for accelerating therapeutic drug discoveries to treat SARS-CoV-2

CompBioMed partners and academics from other research facilities are carrying out research to address the fundamental biological mechanisms of both the SARS-CoV-2 novel corona virus and the COVID-19 disease it causes. The ongoing research also includes an attempt to target the entire viral proteome (entire complement of proteins that is or can be expressed by…

Cardiotoxicity: Supercomputer-based in silico studies by CompBioMed Core Partners aiming to make COVID-19 treatment safer for the heart

The use of certain drugs can disturb the rhythm at which hearts beat.  This disruption can have toxic effects on the heart, which are particularly dangerous for those with underlying medical conditions.  Two drugs which are known to have proarrhythmic effects are the antimalarial drugs azithromycin and hydroxychloroquine. Azithromycin and hydroxychloroquine are thought to be…

Coronavirus Resources Across CompBioMed

Here at CoronaBlog, where we will be providing regular news and updates on the research activities of the CompBioMed members, their collaborators, and the wider scientific community, we have established several other resources to provide information and aid in the COVID-19 research efforts: CompBioMed and Coronavirus provides an overview of the current CompBioMed activities, highlighting the…

Webinar on how AI in Computational Medicine is Leading The Charge in COVID-19 Drug Discovery

There are tens, perhaps hundreds of billions of compounds which can be utilised by the pharmaceutical industry in the development of new drugs.  An exhaustive exploration of more than a handful experimentally is impossible, modern computational techniques are however now beginning to lead the way.  Quantum Chemical calculations run on High Performance Computers (HPCs) allow…

Introducing the CoronaBlog

The ongoing coronavirus pandemic is having a profound impact on how we go about our day to day lives and is dominating world news and conversation (conducted from the recommended social distances, or preferably via video chat or social media).  Since the outbreak was identified in Hubei Province, China in late December last year, the…

CompBioMed and Coronavirus

CompBioMed is active in a vast international consortium across Europe and USA working on urgent coronavirus research. Heading CompBioMed’s efforts in this collaboration is Prof Peter Coveney and the Centre for Computational Science (CCS) at University College London (UCL), together with Leibniz Rechenzentrum (LRZ) and Gauss Centre for Supercomputing (GCS) Director Prof Dieter Kranzlmüller. GCS@LRZ’s…

Toward the first full scale virtual human simulation at the exascale.

A major effort is now underway to perform the first full scale 3-D high fidelity simulations of blood flow in the human vasculature. Led by Peter Coveney within his Centre for Computational Science (CCS) at University College London (UCL), this major, large scale team endeavour, involves colleagues and collaborators from across Europe and the USA.…